Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | President and COO | August 25, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date August 25, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Sale · Disposed 280 · Balance 0 F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. |
| American Depositary SharesSEC Table I · non-derivative | Direct | 12,365 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,365 F1: Each American Depositary Share represents 13 Ordinary Shares. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,270,084 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,270,084 |
| American Depositary SharesSEC Table I · non-derivative | IndirectBy Wife | 4,000 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,000 F1: Each American Depositary Share represents 13 Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2024 Filed Jun 20, 2024 21:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 627 | $159.00 | $99,691.81 |
DisclosureSEC source: 0001651308-24-000072 · wk-form4_1718918703.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,627 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.885 to $159.2191, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:04 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 477,386 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · derivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477,386 Underlying: Ordinary Shares · 477,386 shares Expires 2034-06-04 F7 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F7 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:04 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 253,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,268,849 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F2 · balance_after: Includes 1,443 ordinary shares acquired pursuant to the Company's Third Amended and Restated 2018 Employee Share Purchase Plan. Read SEC document |
| June 26, 2023 Filed Jun 27, 2023 21:20 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,495 | $182.37 | $272,635.68 |
DisclosureSEC source: 0001651308-23-000100 · wf-form4_168790078913526.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 20, 2023 Filed Jun 20, 2023 22:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,753 | $192.44 | $337,355.91 |
DisclosureSEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to mandatory tax withholding provisions in the Reporting Person's restricted share unit award agreements in connection with the vesting of two restricted share unit awards previously granted to the Reporting Person. 1/4th of the securities under one award will vest on each anniversary of June 17, 2020 and under the other award on each anniversary June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.41 to $192.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 22:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 760,851 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · derivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 760,851 Underlying: Ordinary Shares · 760,851 shares Expires 2033-06-14 F8 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F8 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F9 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 22:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 200,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,033,432 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:44 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 824 | $226.15 | $186,348.51 |
DisclosureSEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.835 to $226.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:44 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 789 | $225.27 | $177,739.69 |
DisclosureSEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 824 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.81 to $225.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:44 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,147 | $224.04 | $256,974.22 |
DisclosureSEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,613 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.71 to $224.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 21:44 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 531 | $223.23 | $118,536.88 |
DisclosureSEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,760 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.625 to $223.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:44 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 7,000 | $253.72 | $1,776,037.20 |
DisclosureSEC source: 0001651308-23-000073 · wf-form4_168375144660771.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.65 to $253.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 21:39 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 1,061,814 | $0.00 Strike: $11.98 | $0.00 |
DisclosureSEC source: 0001651308-22-000111 · wf-form4_165610676599580.xml · derivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,814 Underlying: Ordinary Shares · 1,061,814 shares Expires 2032-06-21 F6 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F6 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 21:39 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 187,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-22-000111 · wf-form4_165610676599580.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,867 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 21:45 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,010 | $144.36 | $145,803.70 |
DisclosureSEC source: 0001651308-22-000090 · wf-form4_165593431479531.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F7 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.28 to $144.555, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:45 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 578 | $139.60 | $80,691.11 |
DisclosureSEC source: 0001651308-22-000090 · wf-form4_165593431479531.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $139.91, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 21:42 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 3,410 | $141.99 | $484,201.59 |
DisclosureSEC source: 0001651308-22-000079 · wf-form4_165472451863399.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.80 to $142.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 500 | $169.39 | $84,693.50 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.265 to $169.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $168.15 | $16,814.50 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 700 | $167.32 | $117,121.97 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.00 to $167.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,100 | $165.07 | $181,577.55 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.7434 to $165.565, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 175 | $165.02 | $28,878.96 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to $165.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 3,350 | $163.23 | $546,813.80 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,575 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.79 to $163.625, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 05, 2022 Filed May 6, 2022 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 800 | $161.72 | $129,375.52 |
DisclosureSEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,925 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.10 to $161.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:03 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantRMB Shares | 0 | $30.13 | $0.00 |
DisclosureSEC source: 0001651308-21-000262 · wf-form4_163977857333996.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · security: The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market. F2 · kind: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). F3 · kind: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. F2 · shares: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). F3 · shares: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. F2 · acquired: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). F3 · acquired: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. F2 · balance_after: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). F3 · balance_after: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. F3 · ownership.nature: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $375.00 | $37,500.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 25 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $373.58 | $74,716.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 24 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $371.76 | $74,352.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 23 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $369.98 | $36,998.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 22 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $367.10 | $110,129.82 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 21 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.04 to $367.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $365.93 | $73,185.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 20 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 485 | $364.19 | $176,632.88 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 19 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.81 to $364.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 449 | $363.15 | $163,055.56 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 18 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.71 to $363.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $361.56 | $108,468.99 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 17 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,034 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.38 to $361.655, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $361.03 | $36,103.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 16 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 4,433 | $360.08 | $1,596,221.78 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 15 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.94 to $360.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $358.59 | $71,718.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 14 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,533 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $355.32 | $106,595.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 13 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.92 to $355.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $354.03 | $106,208.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 12 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,033 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.92 to $354.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $352.76 | $35,276.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $351.28 | $105,383.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,433 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.13 to $351.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 164 | $349.66 | $57,344.26 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,733 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.36 to $350.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 449 | $348.70 | $156,567.11 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,897 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.25 to $348.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 420 | $347.20 | $145,826.02 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,346 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.05 to $347.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $346.43 | $103,929.00 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,766 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.05 to $347.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $345.06 | $103,518.99 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,066 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.01 to $345.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $343.12 | $102,935.01 |
DisclosureSEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,366 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.80 to $343.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $331.88 | $33,188.00 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 100 | $329.60 | $32,959.53 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.57 to $330.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,000 | $328.19 | $328,190.60 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.81 to $328.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.